International warning issued on drug-resistance from agricultural fungicides

March 1, 2013

The European Centre for Disease Control has today announced it is examining current evidence for the possible environmental origin of drug resistance in a group of diseases known as Aspergillus infection, following Manchester research.

The EDCD report was prepared with the support of European and US experts, including a team at The University of Manchester.

In its risk assessment, ECDC examines current evidence for the environmental origin of resistance to medical triazoles - a drug used to treat Aspergillus infection. Aspergillosis is usually an incurable caused by the fungus Aspergillus. It is treated using antifungal antibiotics called triazoles but researchers at Manchester have found that the fungus has been able to mutate making treatment ineffective.

The ECDC's report now makes recommendations for further steps to assess the risks and consequences of the environmental usage of triazole fungicides – which are widely used in and material preservation in Europe. Over 90% of are caused by fungi.

ECDC estimated that 2,100,000 patients may be suffering from allergic aspergillosis and 240,000 from chronic aspergillosis across Europe each year. In addition, an estimated 63,250 cases of invasive aspergillosis, annually complicates the management of other diseases including leukaemia, transplantation, and medical intensive care.

Triazole therapy has become the established treatment for human Aspergillus diseases. However, triazole resistance appears to have been increasing in several European countries in recent years. If present, such resistance can severely limit treatment options. The inability to treat patients with triazole due to resistance has a significant impact on patient management (88% mortality) and associated .

Results from published studies suggest that triazole resistance has evolved in the environment and could be driven by the selective pressure of triazole fungicides routinely sprayed on numerous crops. Although evidence supporting this hypothesis is growing, the link between the environmental use of azole fungicides and the development of triazole resistance in patients with Aspergillus infection is not yet proven.

The report concludes on the importance of improved surveillance and diagnosis of resistance in Aspergillus, as well as the development of further environmental and laboratory studies to confirm the environmental hypothesis.

Professor David Denning, Professor of Medicine and Medical Mycology, and Dr Paul Bowyer, a senior lecturer in Molecular Biology, from The University of Manchester were involved in the research. The Manchester researchers, who are based at the University Hospital of South Manchester, have published several papers on azole resistance. Professor Denning, described this phenomenon for the first time in 1997, and is Director of the National Aspergillosis Centre.

Professor Denning welcomed the ECDC's report. He said: "The medical and public health communities need to be alerted to this resistance problem and look at possible means of dealing with it. Resistance rates continue to be problematic in patients."

Explore further: Drug-resistance fears for deadly fungal disease

More information: To view the report, click here.

Related Stories

Drug-resistance fears for deadly fungal disease

May 5, 2011
Deadly human fungal infections caused by certain strains of Aspergillus fungi appear to be developing resistance to current drug treatments at an alarming rate, say scientists.

Mistaken identity: New report highlights the global impact of medical misdiagnosis

December 1, 2011
Researchers have discovered that over a million people worldwide diagnosed with TB go on to develop an incurable but manageable fungal infection which is usually left untreated because it is mistaken for a recurrence of the ...

Baker's yeast protects against fatal infections

August 10, 2011
Injecting mice with simple baker's yeast protects against the fatal fungal infection, aspergillosis, according to research published in the Journal of Medical Microbiology. The work could lead to the development of a human ...

Recommended for you

Google searches can be used to track dengue in underdeveloped countries

July 20, 2017
An analytical tool that combines Google search data with government-provided clinical data can quickly and accurately track dengue fever in less-developed countries, according to new research published in PLOS Computational ...

MRSA emerged years before methicillin was even discovered

July 19, 2017
Methicillin resistant Staphylococcus aureus (MRSA) emerged long before the introduction of the antibiotic methicillin into clinical practice, according to a study published in the open access journal Genome Biology. It was ...

New test distinguishes Zika from similar viral infections

July 18, 2017
A new test is the best-to-date in differentiating Zika virus infections from infections caused by similar viruses. The antibody-based assay, developed by researchers at UC Berkeley and Humabs BioMed, a private biotechnology ...

'Superbugs' study reveals complex picture of E. coli bloodstream infections

July 18, 2017
The first large-scale genetic study of Escherichia coli (E. coli) cultured from patients with bloodstream infections in England showed that drug resistant 'superbugs' are not always out-competing other strains. Research by ...

Ebola virus can persist in monkeys that survived disease, even after symptoms disappear

July 17, 2017
Ebola virus infection can be detected in rhesus monkeys that survive the disease and no longer show symptoms, according to research published by Army scientists in today's online edition of the journal Nature Microbiology. ...

Mountain gorillas have herpes virus similar to that found in humans

July 13, 2017
Scientists from the University of California, Davis, have detected a herpes virus in wild mountain gorillas that is very similar to the Epstein-Barr virus in humans, according to a study published today in the journal Scientific ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.